Research - Radiotherapy Oncology Service

The Radiotherapy Oncology Service of the Hospital Clínic carries out its research through the August Pi Sunyer Biomedical Research Institute (IDIBAPS), in the area of Oncology and Hematology and, specifically, in the groups of

The research of the Radiotherapy Oncology Service aims to improve the response to cancer treatment, as well as to reduce its side effects, through the personalization of radiotherapy treatment based on cutting-edge diagnostic and therapeutic technology.

The main lines of research of the Service are:

The identification of new therapeutic strategies through personalized molecular diagnosis.

Optimization of radiotherapy treatment using biological models of toxicity. 

The research activity is carried out in the following areas:

Clinical research 

• SBRT in lung cancer and oligometastasis.

• Extreme hypofractionation in breast and prostate tumors.

• Intraoperative radiotherapy.

• Participation in international clinical trials. The Service has a Clinical Trials Unit shared with the Hematology and Medical Oncology services.

Translational research

• Radiogenomics in breast cancer.

Research in medical physics

• Improvement of mathematical models used in the calculation of high-complexity radiotherapy treatments.

• In vivo verification of gynecological brachytherapy and intraoperative radiotherapy treatments.

Other lines of research in Radiotherapy Oncology are as follows:

• SBRT in lung tumors
• SBRT oligometastasis
• Extreme hypofractionation in prostate tumors

The Service's research activity is also carried out in multiple national and international research studies:

• Embrace
• Combination of VMAT and new molecules in head and neck and lung
• SBRT in lung tumors
• SBRT oligometastasis